Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline (2017)

Peer-Reviewed Study · Hembree WC, Cohen-Kettenis PT, Gooren L, et al. (Endocrine Society) · September 13, 2017

2017 Endocrine Society guideline recommending GnRH-agonist suppression at Tanner 2, cross-sex hormones around 16, surgery typically 18+. Uses GRADE; most recommendations rest on low or very-low quality evidence (explicitly graded). Two corrigenda issued 2018.

We recommend that clinicians begin pubertal hormone suppression after girls and boys first exhibit physical changes of puberty (Tanner stages G2/B2).

web page (guideline recommendation 1.4 area)

2017 Endocrine Society guideline recommending GnRH-agonist suppression at Tanner 2, cross-sex hormones around 16, surgery typically 18+. Uses GRADE; most recommendations rest on low or very-low quality evidence (explicitly graded). Two corrigenda issued 2018. Society guideline reviewing literature its members produce – Cass Review's guideline appraisal found limited editorial independence across such guidelines.

Election Day is Tuesday, Nov 3. Know who you're voting for: your values vs. their record, with sources.Build my Vote Card →